The markets' rising tide didn't lift every boat this week. Some health-care stocks sprang major leaks.
One of this week's big losers got hurt by the actions of its CEO. Another received a double-whammy of bad news: disappointing clinical results of its own and from a rival. The third stock on this week's list also had a double dose of disappointment from clinical results and an analyst downgrade.
Which health-care stocks got crushed by the market this week? Find out by watching the following slideshow.
Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Clovis Oncology Fell 7.1% in August
Shares retreated after the company reported mixed quarterly results.
Why Clovis Oncology Tumbled 13.5% Today
News of a collaboration with Bristol-Myers Squibb dashed some of investor's hopes that Clovis Oncology could get acquired.
Why Clovis Oncology, Gulfport Energy, and Hertz Global Holdings Slumped Today
These stocks fell to start the week. Find out why.